For someone considering Premier Physicians Weight Loss & Wellness, the first practical question is not which medication appears on its website. It is where the first appointment must happen. The practice advertises virtual consultations for new patients throughout Nevada, but its terms require every new patient to complete an initial consultation and physical evaluation in person in Las Vegas or Reno. That discrepancy matters before arranging travel, requesting time off or paying for a program.
Public documentation consulted October 19, 2026 describes a Nevada medical weight-management practice rather than a clearly documented medication-shipping subscription. Premier advertises semaglutide and tirzepatide prescribing, physician consultations, laboratory monitoring and behavioral support. This review follows the handoffs from scheduling through follow-up, separating those documented services from unresolved questions about enrollment, pharmacy fulfillment and payment. Credentials and service descriptions below are the practice’s statements, not independent verification of its clinicians or operations.
At a glance
- Nevada footprint
- Premier identifies offices in Las Vegas and Reno and advertises telehealth for patients throughout Nevada.Sources: [7]
- Conflicting first-visit instructions
- The FAQ offers new-patient telehealth consultations; the terms require all new patients to attend an initial consultation and physical evaluation in person.
- Documented prescribing
- Premier lists semaglutide as Ozempic and Wegovy and tirzepatide as Mounjaro and Zepbound, and says it prescribes only FDA-approved formulations.Sources: [7]
- Incomplete oral price
- An oral GLP-1 advertisement says “Starting at $149” without identifying the product, billing period, quantity or included services.Sources: [3]
Resolve the first appointment before planning the rest
Premier’s FAQ presents a broad virtual pathway: new-patient consultations, medication management, follow-up visits and continuing program support are advertised for patients throughout Nevada. Its terms state something materially different: “All new patients must complete an initial consultation and physical evaluation in person” at Las Vegas or Reno. The consulted documentation does not explain whether the FAQ is outdated, whether a virtual discussion precedes the required examination, or whether exceptions exist.
For a prospective patient, this is an access issue rather than a wording technicality. Ask the scheduling team which encounter establishes care, whether an office examination is mandatory before prescribing, and whether any preliminary virtual appointment carries a separate charge. Request the answer before making financial or travel commitments. Our guide to preparing for a first consultation offers a framework for organizing those questions without assuming that an appointment guarantees a prescription.
The practice lists separate contact numbers: (702) 822-7400 for Las Vegas and (775) 657-6026 for Reno. Its terms give a Las Vegas contact address of 6930 S Cimarron Road, Suite 220, Las Vegas, NV 89113. Virtual appointments require a smartphone, tablet or computer with a camera and microphone. No first-appointment wait time, confirmed Spanish-language service or interpretation arrangement is established in the consulted documentation.
What the medical assessment is supposed to cover
Premier describes itself as a board-certified obesity medicine practice founded by Dana Trippi, MD. It attributes dual board certification in emergency medicine and obesity medicine, plus nearly 20 years of specialized experience, to its founder. These are provider-reported credentials. The website says prescriptions are managed by board-certified physicians, but the consulted material does not establish which individual would conduct a particular patient’s intake, prescribe medication or handle subsequent concerns.
The advertised initial assessment reviews medical history, weight-loss goals and existing health conditions. Premier says medication plans are monitored and adjusted using health history, laboratory work and treatment response. Its broader program may include evaluation, labs, prescription medication, nutrition and exercise counseling, behavioral support and follow-up. “May include” is important: it describes possible components, not a uniform package in which every service is automatically provided or paid for.
The practice describes candidates broadly as adults and adolescents who have not achieved lasting results through diet and exercise alone, or who have obesity-related conditions. The clinician determines the approach during consultation; complete exclusion criteria and a precise minimum age for the adolescent program are not documented. NIDDK likewise frames medication selection as a discussion of health conditions, other medicines, benefits, side effects and costs—not simply choosing an ingredient from a website.
A named ingredient is not a complete prescription offer
Premier lists semaglutide under the brands Ozempic and Wegovy and tirzepatide under Mounjaro and Zepbound. It says both medications require physician evaluation and a prescription, and that it prescribes only FDA-approved formulations. Those statements describe its advertised prescribing approach. FDA approval belongs to specific products, not to Premier itself, and the brand list does not establish which product a patient would receive or whether insurance would cover it.
Separately, the website advertises oral GLP-1 medications for weight loss “Starting at $149” and directs readers to call. The announcement does not name the medicine, formulation, quantity, supply period or billing interval. Nor does it connect the oral offer explicitly to any listed brand. It would therefore be inaccurate to call this a $149 monthly program, an all-inclusive consultation-and-medication package, or a quoted price for a particular approved oral product.
Before comparing that offer with another service, ask for the exact product name, route, presentation, dispensing pharmacy and written total. Our product and formulation checklist explains why those details should travel together. The consulted documentation does not establish a compounded offering. For general context, FDA says compounded drugs are not FDA approved and recommends them when an individual’s medical needs cannot be met by an approved drug; that guidance does not identify what Premier’s oral advertisement contains.
Where the prescription-to-pharmacy handoff becomes unclear
The public care pathway is more detailed about clinical management than fulfillment. Premier advertises virtual GLP-1 prescriptions and refills, laboratory-result reviews and treatment-plan adjustments. However, the consulted documentation does not identify a dispensing pharmacy, explain whether prescriptions go to a patient-selected pharmacy, or describe office pickup or home delivery. That gap prevents a reliable account of what happens between a prescribing decision and having the medicine available.
The following handoff questions distinguish missing operational information from services the practice actually advertises. They are worth resolving before paying, particularly if access depends on travel or uninterrupted refills. Our guide to the prescription-to-pharmacy handoff provides additional context. No dispensing deadline, shipping charge, delivery area or arrival estimate is established here, and an appointment or prescription approval should not be treated as proof that medication is ready.
Cold-chain arrangements are also undocumented. That does not show that Premier ships medication, or that any shipment would be mishandled; it means a delivery service cannot be evaluated from these pages. If an injectable GLP-1 medicine does arrive warm or with insufficient refrigeration, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. A practice-specific escalation contact would be useful to obtain before relying on any delivery arrangement.
| Stage | What Premier documents | What to confirm |
|---|---|---|
| First encounter | Virtual intake advertised; terms require an office evaluation | Which visit is mandatory before prescribing? |
| Prescription | Physician evaluation and individualized management | Which exact product and presentation are prescribed? |
| Dispensing | No named pharmacy in consulted documentation | Who fills it, and can you choose the pharmacy? |
| Collection or delivery | No documented pickup or shipping process | What are the timing, charges and storage arrangements? |
| Refill | Virtual prescription and refill management advertised | When must requests be submitted, and who handles delays? |
Insurance and memberships create different access routes
Premier says qualification through insurance depends on the insurer, specific plan details and other factors. Its scheduling department offers to check benefits and program eligibility. The published list includes MGM Resorts, Prominence Health Plan and Nevada Public Employees Benefits Plan PPO plans only. Other examples include United Healthcare PPO plans, Health Plan of Nevada Tier 2 PPO only, Blue Cross/Blue Shield PPO/HMO (most commercial plans), and Aetna Community Health Plans (most commercial plans). These restrictions should not be broadened into blanket acceptance of every plan from those organizations.
Consultation coverage and pharmacy coverage are separate questions. An insurer appearing on Premier’s list does not establish coverage for a particular medicine, laboratory test or complete program. Ask scheduling what it can verify, then confirm medication benefits with the plan. The documentation does not establish a patient’s copay, deductible exposure or responsibility for separate services. Our guide to insurance and self-pay care pathways explains how those payment decisions can affect access at different stages.
For uninsured or cash-pay patients, Premier advertises memberships providing physician consultations and medication management at a provider-described reduced cost. Six- and 12-month options list priority appointment access, autopay and structured accountability, alongside a claim of savings up to $900 a year. Base prices and the comparison behind that claim are not published in the consulted material. A care coordinator offers current options and comparisons with insurance, but the listed plan durations do not establish medication supply, mandatory upfront payment or renewal rules.
Follow-up is described, but its service schedule is not
Premier says regular in-person or telehealth visits evaluate progress, manage side effects and support treatment adjustments. It also says laboratory monitoring continues during the program, specifically describing bloodwork intended to identify vitamin B12 deficiency. Those are meaningful descriptions of clinical responsibilities, but they do not establish a standard appointment interval, which laboratory tests every patient receives, or whether testing and additional visits carry separate charges.
Its four-pillar model combines behavior modification, nutritional counseling, exercise planning and pharmacology when medically appropriate. The practice also describes GLP-1 treatment as a long-term tool for many patients and says it builds plans balancing medication with behavioral and nutritional support. This is broader than a prescription-renewal service on paper. Still, patients should ask who delivers each component, how often it occurs, and whether access differs between insured care and a membership.
NIDDK describes follow-up as a matter of treatment response and tolerability, not merely continued payment. That distinction is useful here because Premier does not publish response-time commitments or an after-hours clinical pathway in the consulted documentation. Ask whom to contact about side effects, which concerns require a scheduled visit, and how refill questions are routed. A general promise of ongoing support does not by itself establish immediate access to a prescribing clinician.
Related services may add office visits and separate decisions
Premier advertises FibroScan at both Nevada offices and identifies it as a service requiring an in-person visit. The practice describes an approximately 10-minute scan measuring liver fat and stiffness, without needles or radiation, with results available immediately after the procedure. Those are provider descriptions of the procedure—not a guarantee about appointment availability, physician review time or medication access. Coverage depends on the insurance plan and clinical diagnosis, and private-pay options are offered.
The practice also advertises genetic testing for adults and pediatric patients in selected circumstances, including a strong family history of obesity or lack of response to standard treatment. Its adolescent program is described as age-appropriate and family-centered, with a thorough clinical evaluation before medication and parental consent required for minors. These are related services, not evidence that every adult GLP-1 patient needs genetic testing or that every adolescent qualifies for medication.
Other documented care includes nutritional and medical support for type 2 diabetes, prediabetes and insulin resistance. Premier does not perform bariatric surgery, but offers preoperative and postoperative medical evaluations and support; its surgical-evaluation page names Las Vegas Bariatrics among coordination partners. This wider scope may matter for someone seeking care beyond medication management. It also makes an itemized plan important, because the pages do not establish that these additional services are included in a membership.
Keep communication consent separate from the care agreement
Premier’s terms describe SMS messages for appointment reminders, onboarding steps, insurance verification and follow-up coordination. Participants must be at least 18; for a minor patient, an adult parent or legal guardian must consent and register on the patient’s behalf. These logistics can help explain how the office communicates, but the messaging description does not establish a clinical advice service, guaranteed response time or a substitute for an appointment.
The terms allow patients to stop SMS messages by texting STOP, followed by a confirmation message. That instruction applies to messaging only. It does not cancel a membership, end treatment obligations or create a refund right. Before enrolling, request the actual financial agreement covering billing intervals, renewal, early cancellation, refunds and any remaining payment obligations. The consulted pages do not resolve those points, and the existence of autopay does not answer them.
Questions & answers
Can I start with Premier entirely online?
That is not confirmed. The FAQ advertises new-patient telehealth throughout Nevada, but the terms require all new patients to complete an initial consultation and physical evaluation in Las Vegas or Reno. Ask scheduling which rule applies before booking. Later medication management, laboratory-result review, refills and follow-up are advertised as services that can be handled virtually.
What exactly does the oral GLP-1 offer starting at $149 buy?
The advertisement does not provide enough detail to answer. It leaves the product, formulation, quantity, supply period and included services unspecified. The amount is a starting price, not a documented monthly total. Ask the office for an itemized written quote identifying the medicine and any consultation, laboratory, dispensing or other charges before comparing it with another offer.
Does Premier send medication to my home?
The consulted documentation does not establish home delivery. It advertises prescriptions and refills but does not name a dispensing pharmacy or explain shipping, pickup, delivery charges or fulfillment timing. Ask where the prescription goes and who handles access problems. Do not assume that the clinic’s Nevada telehealth availability also describes a medication-delivery area.
Will an accepted insurance plan cover my medication?
Not necessarily. Premier explicitly makes program eligibility dependent on the insurer, plan details and other factors, and offers scheduling-team assistance with checking benefits. Its insurance list includes plan-specific restrictions. NIDDK also notes that weight-management medication coverage varies. Confirm office-visit benefits and the exact prescription’s pharmacy coverage separately rather than treating insurance acceptance as a complete cost estimate.
Are medications and labs included in a six- or 12-month membership?
The public descriptions do not establish that. Premier says memberships provide access to physician consultations and medication management, and advertises priority appointments and autopay. It does not publish a complete inclusion schedule or base price in the consulted material. Ask for separate lines covering medication, labs, routine visits, additional clinical visits and related testing, plus the billing and cancellation agreement.
How often would Premier review my progress?
Premier promises regular visits to assess progress, manage side effects and adjust treatment, but does not publish a fixed interval. It says plans take account of history, lab work and response, with bloodwork monitored during the program. Before enrolling, ask for the expected follow-up schedule, how unscheduled concerns are handled and whether extra appointments or tests cost more.
Our assessment
Premier documents a broader medical weight-management service than a medication-only storefront: Nevada offices, physician-managed prescribing, virtual follow-up, laboratory monitoring and related metabolic services. Its main documentary weakness is continuity between those pieces. The first-visit contradiction, unidentified oral offer, missing pharmacy pathway and incomplete membership terms leave important practical decisions unresolved. A useful next step is a written care-and-cost outline confirming the required first visit, exact prescribed product, dispensing arrangements, follow-up schedule and financial exit terms. That would make the service easier to evaluate without assuming that advertised access translates into a particular prescription, delivery timeline or total price.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Premier Physicians Weight Loss & Wellness — official website ↗
- Premier Physicians Weight Loss & Wellness — terms of service ↗
- Premier Physicians Weight Loss & Wellness — insurances ↗
- Premier Physicians Weight Loss & Wellness — request appointment ↗
- Premier Physicians Weight Loss & Wellness — faq ↗
- Premier Physicians Weight Loss & Wellness — service/medical weight loss ↗
- Premier Physicians Weight Loss & Wellness — service/membership programs ↗
- Premier Physicians Weight Loss & Wellness — service/surgical weight loss screening ↗
- Premier Physicians Weight Loss & Wellness — service/weight loss medication ↗